Kairos Pharma, Ltd
Fundamentals
Oldest to newest| Line | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating income | none on file | −$1.7M | −$2.3M | −$5.6M |
| Net income | none on file | −$1.8M | −$2.6M | −$5.4M |
| Operating cash flow | none on file | $81,000 | −$4.0M | −$3.4M |
| Cash | $437,000 | $93,000 | $1.3M | $4.5M |
| Shares outstanding | none on file | 10.6M | 13.7M | 20.8M |